August 28th 2023
With an increased incidence of this sexually transmitted infection, a review of an older antibiotic for treatment has shown some clinical benefits in other countries.
July 31st 2023
The vaccine has been approved since late 2019 for adults age 18 and older.
July 26th 2023
The phase 1/2 trial evaluating EBT-101 dosed its first patient in September 2022.
The update refreshes the organization's 2022 guidance on HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and care for key populations, focusing on people in prisons and other closed settings.
April 7th 2023
When taken within 3 days, doxycycline given post-exposure (doxy-PEP) decreased the incidence rates of syphilis, gonorrhea, and chlamydia significantly.
7 Stories for February 7: Observing National Black HIV/AIDS Awareness Day
February 7 is National Black HIV/AIDS Awareness Day (#NBHAAD). In observance, we're recapping stories to raise awareness and work toward ending HIV/AIDS disparities in Black communities.
STIs: Neglected During COVID-19
Sexually transmitted infections (STIs) received little attention during the pandemic, but the truth is the STIs did not stop infection increases shortly after the quarantine.
Economic Impact of Genital Herpes Indicates Developing a Vaccine Should Be Top Priority
Genital herpes (HSV-2) affects quality-of-life but also causes substantial economic losses, especially in low- and middle-income countries.
Do People Who Inject Drugs Use HIV PrEP?
HIV PrEP prescriptions increased from 0 among people who use injection drugs, but overall PrEP uptake remains low.
Revisiting Old Foes: Updates on HSV
Herpes simplex viruses are chronic infections that underscore racial and ethnic
disparities and are afflicting adolescents in increasing numbers.
Disseminated Gonococcal Infection Complicated by Suspected Osteomyelitis of Humeral Head
Gonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.
Merck Initiates a Phase 3 Program for Islatravir
This will include 3 trials to examine the therapy in different formulations in HIV studies.
HIV Prevalence High Among Female Sex Workers But Interventions Have Positive Effect
There are a number of programs designed to help lower rates of infection and transmission amongst this industry's workforce in South Africa.
Tracking the Lifespan of HIV Host Cells
Investigators noted 2 distinct phases of HIV virus levels, meaning any infected cells that survive treatment can become latent, only to reignite HIV infection after antiretroviral therapy is stopped.
A Study of HIV and STIs Among People With Monkeypox
WHO Provides Guidelines on HIV, Hepatitis and STIs in Key Populations
WHO guidelines on HIV, hepatitis and STIs focus on populations with high risk of infections but low inclusion in prevention and treatment programs.
HIV Associated with Rapid Age Acceleration, New Study Finds
The study was longitudinal in nature, comparing at-risk people who became infected with HIV to at-risk people who did not.
Incidence of STIs Stabilized Among Gay and Bisexual Men Using HIV PrEP
After widespread implementation of HIV pre-exposure prophylaxis (PrEP) among gay and bisexual men in Australia, population-level incidence of chlamydia and gonorrhea stabilized, allaying fears that PrEP would lead to a rise in STIs, a recent study found.
Fostemsavir Improves Outcomes for Treatment-Resistant HIV Patients
After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.
Middle East, North Africa Face Emerging HIV Epidemics With Lagging Response
HIV epidemics are emerging among key populations in the Middle East and North Africa, and the region ranks lowest globally in response indicators.
Identifying Monkeypox Viral DNA in Bodily Fluid Samples
Investigators found potentially infectious monkeypox virus DNA in saliva and semen.
New Treatment for HIV, Visceral Leishmaniasis Coinfection
Visceral leishmaniasis patients coinfected with HIV are vulnerable to other comorbidities including tuberculosis and cryptococcal meningitis but also to degrees of stigmatization and human rights issues.
EMA Moves Forward with Recommendation for Lenacapavir based on 26-Week Data
A positive recommendation now heads to the European Commission, which can grant marketing authorization for 27 European Union member states.
HIV Testing and Diagnoses Drop During COVID-19 Pandemic
The commitment to ending the HIV epidemic endures, despite drops in testing and new diagnoses during the COVID-19 pandemic.
An Unintended Consequence for High HIV Drug Prices
“It’s time to ensure widespread availability by promoting access to safe, effective, and sustainably priced medications, rather than providing incentives to prescribe higher-cost alternatives,” the authors said.
Public Health Watch: New CDC Surveillance Report Documents Continued Rise in Some STDs
Findings highlight need for innovative prevention strategies, experts say.
First In-Africa Clinical Trial of mRNA HIV Vaccine
Today, the International AIDS Vaccine Initiative (IAVI) and Moderna announced they will soon launch a phase 1 clinical trial for their HIV vaccine candidate, administered with mRNA technology to develop broadly neutralizing antibodies.
“Part of the Lenacapavir Story”: Expanding Treatments to People with Multidrug-Resistant HIV
In Part 2 of a video interview, Sornana Segal-Maurer, MD, discusses the newly published research findings that detail the potential of lenacapavir.
Lenacapavir for HIV Infection in a Multidrug-Resistant Study Cohort
Could lenacapavir be the answer for people with multidrug-resistant HIV infection? Principal investigator Sorana Segal-Maurer discusses the promising trial results in this challenging cohort (Interview part 1).
HIV Drug Slows Colorectal Cancer Disease Progression
In a study of 32 patients with fourth-line metastatic colorectal cancer, the HIV drug lamivudine slowed disease progression in a quarter of participants.
Woman Achieves HIV Remission after Cord Blood Stem Cell Transplant
Two other male patients were previously known to be in HIV remission, but this is the first woman and first cord blood stem cell transplant case.
Novel Strategies to Identify and Eliminate Latent HIV Cells
HIV reservoirs can remain dormant, reigniting infection at an opportune moment. New strategies seek to reignite these viral reservoirs so they can be identified and destroyed by the immune system.
PrEP Prescription Fills Declined in Early Part of COVID-19 Pandemic
PrEP prescription initiations and fills dropped during the early parts of the COVID-19 pandemic, according to investigators from the NY State Department of Health.
All HIV Patients Should be Tested for Tuberculosis in High-Burden Areas
The meta-analysis included 6 studies, of which 5 were conducted in sub-Saharan Africa, showed that the diagnostic accuracy for Xpert testing was similar to the former symptom screening and rapid test format.
PrEP User Adherence to Regular HIV Testing Recommendations
In Germany, HIV pre-exposure prophylaxis users are recommended to receive regular HIV, STI, and renal function testing. How frequently are PrEP users getting tested?
2 Clarke Drive Cranbury, NJ 08512